Document Header
This is a regulatory disclosure filed by Jubilant Pharmova Limited with the BSE Limited and the National Stock Exchange of India Limited.
The disclosure is made pursuant to Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The purpose is to inform that the audio recording of an Earnings Webinar discussing the company's Un-audited Financial Results has been uploaded to the company's website.
The webinar covered the financial results for both a quarter and a half-year period, specifically the results ended September 30, 2026. The results discussed were presented on both a Standalone and Consolidated basis. The webinar itself was held on November 16, 2026, and the audio recording was uploaded on the same date.
The specific URL for accessing the audio call recording is provided: jubilantpharmova.com/Uploads/files/102q9fileJubilantPharmova-Earnings-Nov16-2026Audio_compressed.mp3
The letter is signed by Naresh Kapoor, who is identified as the Company Secretary for Jubilant Pharmova Limited, authenticating the disclosure.